A
$ Value
$0
Shares
10,787
Price
$0
Filed
May 19
Insider
Name
Dunsire Deborah
Title
—
CIK
0001332764
Roles
Director
Transaction Details
Transaction Date
2025-05-15
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
10,787
Footnotes
Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) May 15, 2026. | The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) May 15, 2026.
Filing Info
Dunsire Deborah's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-07-30 | MCK | A | $0 |
| 2025-05-15 | RARE | A | $0 |
| 2025-05-15 | RARE | A | $0 |
Other Insiders at RARE (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
KAKKIS EMIL D
President & CEO
|
— | $1.2M | 2026-04-16 |
|
Huizenga Theodore Alan
SVP, Chief Accounting Officer
|
— | $37K | 2026-03-02 |
|
Huang Dennis Karl
See Remarks
|
— | — | 2026-04-16 |
|
Pinion John Richard
See Remarks
|
— | $229K | 2026-04-16 |
|
Crombez Eric
EVP and Chief Medical Officer
|
— | $160K | 2026-04-16 |
|
Parschauer Karah Herdman
EVP and Chief Legal Officer
|
— | $394K | 2026-04-16 |
|
Harris Erik
EVP & Chief Commercial Officer
|
— | $240K | 2026-04-16 |
|
Horn Howard
Chief Financial Officer
|
— | $398K | 2026-04-16 |